Timothy C. Barabe's most recent trade in Heartflow Inc was a trade of 5,000 Stock Option done . Disclosure was reported to the exchange on July 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heartflow Inc | Timothy C. Barabe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2026 | 5,000 | 18,710 | - | - | Stock Option | |
| Heartflow Inc | Timothy C. Barabe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 17 Jul 2026 | 5,000 | 184,521 | - | 19 | 95,000 | Common Stock |
| Heartflow Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 16,075 | 16,075 | - | - | Stock Option | |
| Heartflow Inc | Timothy C. Barabe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 11 Mar 2026 | 8,667 | 179,521 | - | 2.2 | 19,241 | Common Stock |
| Heartflow Inc | Timothy C. Barabe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 8,667 | 15,412 | - | - | Stock Option | |
| Cartesian Therapeutics Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 2,600 | 56,966 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Timothy C. Barabe | Director | Purchase of securities on an exchange or from another person at price $ 6.86 per share. | 04 Dec 2025 | 30,000 | 54,366 (0%) | 0% | 6.9 | 205,797 | Common Stock |
| Heartflow Inc | Timothy C. Barabe | Director | 07 Aug 2025 | 131,578 | 0 | - | - | Convertible Promissory Note | ||
| Heartflow Inc | Timothy C. Barabe | Director | 07 Aug 2025 | 131,578 | 168,357 | - | - | Common Stock | ||
| Heartflow Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 23,710 | 23,710 | - | - | Stock Option | |
| Cartesian Therapeutics Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 24,366 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Timothy C. Barabe | Director | Purchase of securities on an exchange or from another person at price $ 12.70 per share. | 12 Aug 2024 | 7,500 | 21,766 (0%) | 0% | 12.7 | 95,250 | Common Stock |
| Selecta Biosciences Inc | Barabe Timothy C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | C. Timothy Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 178,000 | 428,013 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Timothy C. Barabe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Timothy C. Barabe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 14 Jan 2022 | 10,000 | 200,013 (0%) | 0% | 2.1 | 21,000 | Common Stock |
| Selecta Biosciences Inc | Timothy C. Barabe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Timothy C. Barabe | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 18 Aug 2021 | 9,000 | 190,013 (0%) | 0% | 4 | 36,000 | Common Stock |